MEI Pharma Secures Over $100 Million Funding Commitment to Launch Litecoin Treasury Strategy
BlockBeats News, July 19th, Titan Partners Group and crypto investment firm GSR are co-leading a strategic transformation of the US pharmaceutical company MEI Pharma (NASDAQ: MEIP), driving the establishment of a dedicated Litecoin treasury strategy. Currently, there has been over $100 million in funding commitments to this project.
It is worth mentioning that Litecoin creator Charlie Lee has agreed to join the MEI Pharma board of directors. Furthermore, the Litecoin Foundation has also invested in MEI Pharma as the company's treasury strategy aligns closely with the Litecoin Foundation's core mission of promoting global Litecoin adoption.
Das könnte Ihnen auch gefallen
Gewinner
Neueste Krypto-Nachrichten
Coinbase to Include HBAR, MANTLE in COIN50 Index for Q4
In einem Anthropic-Simulationstest entdeckten KI-Agenten eine 4,6 Millionen US-Dollar teure Smart Contract-Schwachstelle.
Zukünftige Fed-Meetings riskieren verstärkte Meinungsverschiedenheiten, die die Marktvolatilität anheizen
Tom Lee: Risiko-Rendite-Verhältnis von BTC und ETH wird attraktiv
Coinbase ist jetzt live mit Rayls (RLS) Spot Trading
Kundenservice:@weikecs
Geschäftliche Zusammenarbeit:@weikecs
Quant-Trading & MM:[email protected]
VIP-Services:[email protected]